Clinical Trials Logo

Clinical Trial Summary

The aim of the study is to enroll approximately 200 cases from 10 research centers nationwide, completed left atrial appendage occlusion (LAAO) successfully, and give apixaban (5 mg bid) postoperatively.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

  • Evaluate the Safety and Efficacy of Apixaban

NCT number NCT04550637
Study type Observational [Patient Registry]
Source Shanghai Zhongshan Hospital
Contact Xiaochun Zhang
Phone 15002121366
Status Recruiting
Start date July 4, 2022
Completion date December 31, 2024